<DOC>
	<DOCNO>NCT00070733</DOCNO>
	<brief_summary>The enzyme 5-alpha reductase present small amount muscle convert testosterone dihydrotestosterone ( DHT ) . Testosterone affect lean body tissue , muscle size , muscle strength , sexual function men . This study evaluate 5-alpha reductase influence effect testosterone young healthy men .</brief_summary>
	<brief_title>The Effect 5-Alpha Reductase Testosterone Men</brief_title>
	<detailed_description>Testosterone , predominant circulate androgen men , serf active hormone target tissue ; however , testosterone effect target organ require conversion two active metabolite , estradiol 17-beta DHT . The role 5-alpha reductase mediate testosterone 's effect muscle sexual function remain unclear . This study determine whether 5-alpha reduction testosterone DHT necessary mediating effect fat-free mass , muscle size , muscle strength , leg power men . The study also evaluate necessity 5-alpha reductase maintenance androgen effect sexual function ( sexual desire , overall sexual activity , nocturnal penile tumescence [ NPT ] , response visual erotic stimulus , penile rigidity ) men . Participants study treat drug suppress endogenous testosterone production . Participants randomly assign receive either testosterone placebo testosterone 5-alpha reductase inhibitor dutasteride . Testosterone administered weekly ; dutasteride placebo administer daily . Diet exercise standardize across group . Participants assess study entry Week 20 . Assessments include measurement DEXA scan , MRI scan , muscle performance sexual function test . Participants also blood test safety monitoring ; blood test include measure hematocrit , liver enzyme ( AST ALT ) , prostate specific antigen ( PSA ) , cholesterol .</detailed_description>
	<mesh_term>Sexual Dysfunction , Physiological</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Inclusion Criteria General good health capable undergoing strength test Normal testosterone ( 3001100 ng/dL ) , LH , FSH level Exclusion Criteria Currently participate competitive sport Mental state would preclude complete understand protocol compliance Disorder know cause associate hypogonadism ( e.g. , pituitary tumor , hyperprolactinemia , HIV infection , Klinefelter 's Syndrome ) More 20 % ideal body weight Disabilities would prevent participation strength test ( e.g. , amputation limb , blindness , severe arthritis , angina , neurologic disorder Parkinson 's disease , stroke , myopathy ) Uncontrolled hypertension , diabetes , congestive heart failure , chronic obstructive lung disease Alcohol drug dependence 6 month prior study entry Disorders might exacerbate androgen treatment ( e.g. , benign prostatic hyperplasia prostate cancer , erythrocytosis [ hematocrit &gt; 51 % baseline ] , sleep apnea assess Berlin 's questionnaire ) Serum PSA level &gt; 4 microg/L AST , ALT , alkaline phosphatase elevation great three time upper limit normal Creatinine great 2 mg/dL Medications might affect muscle bone metabolism ( e.g. , glucocorticoid , rhGH , androgenic steroid , oral androgen precursor androstenedione DHEA ) androgen metabolism , action , clearance ( e.g. , dilantin , phenobarbitol , aldactone , flutamide , finasteride )</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2003</verification_date>
	<keyword>Testosterone</keyword>
	<keyword>5-alpha Reductase</keyword>
	<keyword>Muscle Strength</keyword>
	<keyword>Libido</keyword>
	<keyword>Sexual Function</keyword>
	<keyword>Muscle Mass</keyword>
	<keyword>Testosterone 5-alpha-Reductase</keyword>
</DOC>